Status:
COMPLETED
Fish Oil Affects Cognition and ADHD Symptoms in Adults With Autism Spectrum Disorder
Lead Sponsor:
University of Copenhagen
Conditions:
Autism Spectrum Disorder
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The prevalence of autism spectrum disorder (ASD) is rising and was estimated to have a prevalence of around 1.5% in developed countries in 2016. ASD is characterized by impairments in social interacti...
Detailed Description
The aim of the study was to examine the effect of fish oil (FO) on sustained attention and visuospatial short-term memory memory, as well as cognitive inhibition, executive function, and core symptoms...
Eligibility Criteria
Inclusion
- A clinical diagnosis of ASD (Asperger's syndrome, Autistic disorder, or a not otherwise specified pervasive developmental disorder).
Exclusion
- Supplementation with n-3 long-chain polyunsaturated fatty acids 1 mo prior to the intervention or during the intervention.
- Major changes to psychopharmacological treatment 1 mo prior to the intervention or during the intervention.
Key Trial Info
Start Date :
December 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 13 2020
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04779632
Start Date
December 10 2019
End Date
February 13 2020
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Copenhagen - Department of Nutrition & Exercise
Copenhagen, Frederiksberg, Denmark, 1958